In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

To survive in ever-changing conditions in the body, cancer cells often need to alter their metabolism. 1 This ability to adapt is especially critical for their spread to other parts of the body. “This ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

According to Japanese scientists, certain bacteria found in the digestive systems of frogs and lizards can completely ...